Cargando…
Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory
BACKGROUND: Resveratrol is a natural polyphenol that has been proposed to improve glycemic control in diabetes, by mechanisms that involve improvement in insulin secretion and activity. In type 1 diabetes (T1D), in which insulin therapy is obligatory, resveratrol treatment has never been investigate...
Autores principales: | Yonamine, Caio Yogi, Pinheiro-Machado, Erika, Michalani, Maria Luiza, Freitas, Helayne Soares, Okamoto, Maristela Mitiko, Corrêa-Giannella, Maria Lucia, Machado, Ubiratan Fabres |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928352/ https://www.ncbi.nlm.nih.gov/pubmed/27366200 http://dx.doi.org/10.1186/s12986-016-0103-0 |
Ejemplares similares
-
Resveratrol Improves Glycemic Control in Type 2 Diabetic Obese Mice by Regulating Glucose Transporter Expression in Skeletal Muscle and Liver
por: Yonamine, Caio Y., et al.
Publicado: (2017) -
Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia
por: Yonamine, Caio Yogi, et al.
Publicado: (2023) -
Increased SGLT1 expression in salivary gland ductal cells correlates with hyposalivation in diabetic and hypertensive rats
por: Sabino-Silva, Robinson, et al.
Publicado: (2013) -
Estrogen Receptor 1 (ESR1) Enhances Slc2a4/GLUT4 Expression by a SP1 Cooperative Mechanism
por: Barreto-Andrade, João Nilton, et al.
Publicado: (2018) -
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
por: David-Silva, Aline, et al.
Publicado: (2020)